3 results match your criteria: "University of Minnesota and University of Minnesota Cancer Center[Affiliation]"
The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin.
J Thorac Oncol
April 2011
Division of Hematology, Oncology and Transplantation, University of Minnesota and University of Minnesota Cancer Center, Minneapolis, MN 55455, USA.
Introduction: Ritonavir is a potential therapeutic agent in lung cancer, but its targets in lung adenocarcinoma are unknown, as are candidate biomarkers for its activity.
Methods: RNAi was used to identify genes whose expression affects ritonavir sensitivity. Synergy between ritonavir, gemcitabine, and cisplatin was tested by isobologram analysis.
Null association between frequency of cured meat consumption and methylvaline and ethylvaline hemoglobin adduct levels: the N-nitroso brain cancer hypothesis.
Cancer Epidemiol Biomarkers Prev
April 2002
Division of Pediatric Epidemiology, Department of Pediatrics, University of Minnesota and University of Minnesota Cancer Center, Minneapolis, Minnesota 55455, USA.
Is local excision adequate therapy for early rectal cancer?
Dis Colon Rectum
August 2000
Department of Surgery, University of Minnesota and University of Minnesota Cancer Center, Minneapolis, USA.
Purpose: Radical surgery of rectal cancer is associated with significant morbidity, and some patients with low-lying lesions must accept a permanent colostomy. Several studies have suggested satisfactory tumor control after local excision of early rectal cancer. The purpose of this study was to compare recurrence and survival rates after treating early rectal cancers with local excision and radical surgery.
View Article and Find Full Text PDF